Position in PTCT
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$40,866,162
+$40,525,308 QoQ
Shares Held
500,995
+9913.9% QoQ
Ownership
0.600%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
#48
of 383 holders
Holding Since
Mar 2020
24 quarters on record
Voting authority
Sole 86%
Shared 14%
None 0%
Common Shares in PTCT Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026AMERICAN CENTURY COMPANIES INC holds $3,618,743,392 across 179 Biotechnology names. PTCT ranks #28 (1.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
1,853,956 | $558,096,374 | |
| 2 | ASND |
Ascendis Pharma A/S
|
1,400,575 | $373,561,364 | |
| 3 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
580,901 | $288,550,953 | |
| 4 | ARGX |
Argenx SE
|
173,193 | $160,683,269 | |
| 5 | IONS |
Ionis Pharmaceuticals Inc
|
1,947,076 | $154,383,656 | |
| 6 | EXEL |
Exelixis, Inc.
|
1,791,664 | $97,484,438 | |
| 7 | HRMY |
Harmony Biosciences Holdings, Inc.
|
2,539,512 | $92,463,631 | |
| 8 | GPCR |
Structure Therapeutics Inc.
|
1,682,179 | $90,282,546 |
All Filings in PTCT
Export CSV
24 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $40,866,162 | 500,995 | Shares | Defined | 2026-08-12 | |
| 2026-03-31 | $340,854 | 5,003 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $348,580 | 4,589 | Shares | Defined | 2026-02-13 | |
| 2025-09-30 | $1,114,295 | 18,157 | Shares | Defined | 2025-11-12 | |
| 2025-06-30 | $2,141,340 | 43,844 | Shares | Defined | 2025-08-12 | |
| 2025-03-31 | $2,866,652 | 56,253 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $2,715,171 | 60,150 | Shares | Defined | 2025-02-11 | |
| 2024-09-30 | $1,337,826 | 36,060 | Shares | Defined | 2024-11-12 | |
| 2024-06-30 | $1,143,508 | 37,394 | Shares | Defined | 2024-08-07 | |
| 2024-03-31 | $521,263 | 17,919 | Shares | Defined | 2024-05-14 | |
| 2023-12-31 | $708,512 | 25,708 | Shares | Defined | 2024-02-13 | |
| 2023-09-30 | $529,996 | 23,650 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $902,507 | 22,191 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $415,712 | 8,582 | Shares | Defined | 2023-05-11 | |
| 2022-12-31 | $306,772 | 8,037 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $825,488 | 16,444 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $407,410 | 10,170 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $491,372 | 13,170 | Shares | Defined | 2022-05-11 | |
| 2021-12-31 | $524,561 | 13,170 | Shares | Defined | 2022-02-07 | |
| 2021-09-30 | $490,055 | 13,170 | Shares | Defined | 2021-11-10 | |
| 2020-12-31 | $615,121 | 10,079 | Shares | Defined | 2021-02-12 | |
| 2020-09-30 | $611,910 | 13,089 | Shares | Defined | 2020-11-13 | |
| 2020-06-30 | $10,860,440 | 214,041 | Shares | Defined | 2020-08-13 | |
| 2020-03-31 | $8,790,311 | 197,048 | Shares | Defined | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||